PerCP/Cyanine5.5 Anti-Mouse CD25 Antibody[PC-61.5.3] (E-AB-F1102J) elabscience

$160.00
In stock
SKU
E-AB-F1102J
SizePrice (USD)
100Tests$160.00
50Tests$98.00
100Tests×2$275.00

Product Details

AbbreCD25
SynonymsIL-2 receptor subunit alpha, IL-2-RA, IL-2R subunit alpha, IL2-RA, IL2RA, Interleukin-2 receptor subunit alpha, TAC antigen, p55
SwissprotP01590
ReactivityMouse
HostRat
ClonalityMonoclonal
ClonePC-61.5.3
IsotypeRat IgG1, κ
Isotype ControlPerCP/Cyanine5.5 Rat IgG1, κ Isotype Control[HRPN]
ApplicationsFCM
ConjugationPerCP/Cyanine 5.5
Concentration5 μL/Test
BufferPhosphate buffered solution, pH 7.2, containing 0.09% stabilizer.
Research AreasImmunology
Cellular LocalizationMembrane

Product Description

Conjugation Information: PerCP/Cyanine5.5 is designed to be excited by the blue laser (488 nm) and detected using an optical filter centered near 675 nm (e.g., a 690/50 nm bandpass filter).

Background: CD25 is a 55 kD glycoprotein, also known as the low affinity IL-2Rα, Ly-43, p55, or Tac. It is expressed on activated T and B cells, thymocyte subset, pre-B cells, and T regulatory cells. In association with CD122 (IL-2Rβ) and CD132(common γ chain), CD25 forms the high affinity signaling IL-2 receptor.

Storage and Shipping

StorageThis product can be stored at 2-8°C for 24 months. Please protected from prolonged exposure to light and do not freeze.
ShippingIce bag
  1. A ROS-responsive “one-two punch” nanozyme for self-supplying oxygen and suppressing immune rejection in heart transplantation
    Journal: Materials Today Bio | Year: 2026 | Impact Factor: 11.000
    DOI: 10.1016/j.mtbio.2026.103161 | Reactivity: Mouse | Sample Type: spleen tissue
  2. Shewanella oneidensis Metabolically Engineered with Prussian Blue for Synergistic Tumor Microenvironment Remodeling and Photodynamic Breast Tumor Elimination
    Journal: ACS Biomaterials Science & Engineering | Year: 2026 | Impact Factor: 5.500
    DOI: 10.1021/acsbiomaterials.6c00087 | Reactivity: Mouse | Sample Type: Mouse breast cancer (4T1) cell
  3. Synergistic potentiation of anti-PD-L1 therapy via Glut1-targeted berberine liposomes functionalized with Rg3 in triple-negative breast cancer
    Journal: JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY | Year: 2026 | Impact Factor: 4.900
    DOI: 10.1016/j.jddst.2026.108104
  4. Semaglutide decelerates the growth and progression of breast cancer by enhancing the acquired antitumor immunity
    Journal: BIOMEDICINE & PHARMACOTHERAPY | Year: 2024 | Impact Factor: 6.900
    DOI: 10.1016/j.biopha.2024.117668 | Reactivity: Mouse | Sample Type: spleen tissue,4T1 cell-Xenograft
  5. Effect and mechanisms of shikonin on breast cancer cells in vitro and in vivo
    Journal: BMC Complementary Medicine and Therapies | Year: 2024 | Impact Factor: 3.300
    DOI: 10.1186/s12906-024-04671-3 | Reactivity: Mouse | Sample Type: Spleen immune cell
  6. Compromised melanocyte survival due to decreased suppression of CD4+ & CD8+ resident memory T cells by impaired TRM-regulatory T cells in generalized vitiligo patients
    Journal: EXPERIMENTAL DERMATOLOGY | Year: 2023 | Impact Factor: 3.600
    DOI: 10.1111/exd.14982 | Reactivity: Human | Sample Type: skin biopsies

Reviews

Write Your Own Review
You're reviewing:PerCP/Cyanine5.5 Anti-Mouse CD25 Antibody[PC-61.5.3] (E-AB-F1102J) elabscience
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.